Skip to content

Study on duration of residual neuromuscular block

A Comparative Study on the Duration of Residual Neuromuscular Block after administration of Neostigmine versus Sugammadex at two visible twitches during Train-of-Four monitoring - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091387
Enrollment
80
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Comparison of Duration of Residual Neuromuscular Block: Compare Residual Neuromuscular Block Between Neostigmine and Sugammadex using Train-of-Four Monitoring Control Intervention1: Com

Sponsors

Dr Nishamoni Mali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to give informed written consent,ASA I-II patients,patients with BMI less than 30 kg/m2,patients undergoing Elective Surgery under General Anesthesia

Exclusion criteria

Exclusion criteria: Allergic to any study Drugs,Patients with severe systemic disease,Pregnant or Lactating women

Design outcomes

Primary

MeasureTime frame
Time gap between the loss of visual fade to return of TOF Ratio more than or equal to 0.9 after administration of Neostigmine or Sugammadex at two visible twitches during Train-of-Four monitoringTimepoint: Time from administration of reversal to TOF Ratio 0.70,0.80,0.90

Secondary

MeasureTime frame
1.Duration of Surgery 2.Administration & Dosage of Neuromuscular Blocking Agents 3.Heart Rate,Systolic Blood Pressure,Diastolic Blood Pressure,Mean Arterial Pressure 4.Post Operative Residual Neuromuscular Block Associated Adverse eventsTimepoint: Before administration of reversal agents,1 minute,5 minutes & 10 minutes after administration of reversal agents

Countries

India

Contacts

Public ContactDr Dilip Kumar Saloi

Department of Anaesthesiology and Critical Care,Tezpur Medical College and Hospital,Tezpur

dilipkumarsaloi@gmail.com9101291318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026